Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

CPMP recommends approval of Epivir

April 26, 1996

Fomivirsen clinical data presented at international symposium

April 26, 1996

Androgel-DHT in phase II for AIDS indications

April 19, 1996

GEM-91 + AZT enters clinical trials in Europe

April 19, 1996

Ryan develops improved formulation of CoQ10

April 19, 1996

BufferGel development assisted by NIH

April 19, 1996

Didanosine + hydroxyurea effective in reducing HIV viral load

April 19, 1996

Ciba-Geigy selects CGP-61755 for development

April 19, 1996

Canada, Brazil approve Invirase for marketing

April 19, 1996

HIV protease inhibitors described by Hoechst Marion Roussel

April 19, 1996

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...